Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024
                     
 Global Influenza Vaccines Market - Overview
The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is 
presenting ample opportunities to the industry’s players. Influenza viruses are considered as a 
major cause of morbidity and mortality worldwide.
 Global - Influenza Vaccines Market (Million US$), 2011-2017
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
Global Influenza Vaccines Market and Forecast
The vast population base together with significantly low vaccination coverage in emerging 
markets, introduction of new vaccines, rising government support for immunization and 
growing awareness of the value of influenza vaccine in preventing disease are the prominent 
factors that will drive the influenza vaccines market. However, shortage of vaccine supply due 
to genetic assortment of the viral strains is surging the need for updating vaccines each year 
by the manufacturers.  This is a major factor restraining market growth. 
Global - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018-2024
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
Global Influenza Vaccines Market – Regional Analysis
By Region - Global Influenza Vaccines Market Share (Percent), 2017
• Geographically, North 
America is the largest market 
for influenza vaccines 
capturing over 48% market 
share in 2017. 
• Asia is the second largest 
market for influenza vaccines.
• By Region - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2024Europe is the third largest 
market for influenza vaccines, 
followed by Latin America.
• Australasia accounted for 
least share of the influenza 
vaccines market in 2017.
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
Global Influenza Vaccines Market – Country Wise Analysis
• On the basis of country, By Country - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2024
United States captures 
majority of the influenza 
vaccines market. 
• Japan is the second largest 
market for influenza vaccines. 
• China, Brazil and India are 
the third, fourth and fifth 
leading market for influenza 
vaccines respectively.
• Canada, Germany, France, 
UK, Italy, Spain and South 
Korea are the other leading 
market for influenza vaccines.
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
 Global Influenza Vaccines Market – Brands Analysis
• In the influenza vaccines brand sales segment, By Brand – Global Influenza Vaccines Market Share (Percent), 2017
Sanofi’s Fluzone holds the maximum share of 
the market being followed by 
Fluvirin/Flucelvax. 
• In May 2016, the cell-based Flucelvax 
quadrivalent shot was approved by the FDA. 
• GSK’s Fluarix/FluLaval accounts for the third 
highest share of the influenza vaccines 
market. 
• Fluad is the first and only adjuvanted seasonal 
influenza vaccine in the US for adults aged 65 
and older.
• Flublok has captured least share of the By Brand – Forecast for Global Influenza Vaccines Market Share (Percent), 2024
influenza vaccines market. 
• In October 2016, Protein Sciences received 
approval from the FDA for the quadrivalent 
version of Flublok vaccine.
• On August 28, 2017 - Sanofi announced that it 
has completed the acquisition of Protein 
Sciences. 
• In February 2018, SK Chemicals Co. signed a 
US$ 155 Million deal to license cell culture 
technology to Sanofi Pasteur Inc. for 
development of a universal influenza vaccine.
Note: Dummy Data, Actual figures given in the report
www.igateresearch.com
Continue (www.igateresearch.com)
iGATE RESEARCH report titled “Global Influenza Vaccines Market, 
Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, 
Major Deals - Forecast to 2024” provides a comprehensive 
assessment of the fast-evolving, high-growth influenza vaccines 
market landscape. 
www.igateresearch.com
This 224 Page report with 139 Figures and 12 Tables has been analyzed from 5 viewpoints:
1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2024)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2024) 
3. Global - Influenza Vaccines Brand Sales and Forecast to 2024
4. Global Influenza Vaccines Market - Major Deals
5. Global Influenza Vaccines Market - Driving Factors and Challenge
www.igateresearch.com
Continue (www.igateresearch.com)
Global Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region 
1. North America 4. Asia
2. Latin America 5. Australasia
3. Europe
Global Influenza Vaccines Market, Persons Vaccinated and Forecast - 
Country Wise Distribution (25 Countries Covered)
1. United States 14. Sweden
2. Canada 15. Australia
3. Brazil 16. New Zealand
4. Mexico 17. Japan
5. Germany 18. China
6. France 19. India
7. Italy 20. South Korea
8. Spain 21. Singapore
9. United Kingdom 22. Hong Kong
10. Netherlands 23. Malaysia
11. Ireland 24. Thailand
12. Denmark 25. Indonesia
13. Luxembourg
www.igateresearch.com
Continue (www.igateresearch.com)
Global Influenza Vaccines Brand Sales and Forecast - 8 Brands Analyzed
1. Fluarix/FluLaval 
2. Fluzone 
3. Fluvirin/Flucelvax 
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok
8. Fluad 
www.igateresearch.com
Published By
  iGATE RESEARCH
   Phone: +91-858-684-0791 (India)
               +91-821-092-7469 (India)
   Email: [email protected]
   Internet: www.igateresearch.com
 
 
 
 
 
www.igateresearch.com
Format
Report Title:  
“Global Influenza Vaccines Market, Persons Vaccinated, Brand
 Analysis, Size, Share, Growth, Trends, Major Deals - Forecast 
to 2024”
To Order the Report Visit:
http://www.igateresearch.com/
Single User License US$ 1,800
Hard-copy Mail Delivery US$ 2,000
CD-ROM Mail Delivery US$ 2,000
Multi User License US$ 2,500
www.igateresearch.com
Order the Report
iGATE RESEARCH PVT. LTD.
Web: www.igateresearch.com
To order the Report:
E-Mail:  [email protected]
Contact No. : +91-858-684-0791, +91-821-092-7469 (INDIA)
For Report Related Query:
E-Mail:  [email protected]
Contact No. : +91-858-684-0791, +91-821-092-7469 (INDIA)
www.igateresearch.com